- 著者
-
Kimio Satoh
Jun Takahashi
Yasuharu Matsumoto
Shunsuke Tatebe
Tatsuo Aoki
Yoku Kikuchi
Kiyotaka Hao
Kazuma Ohyama
Masamichi Nogi
Akira Suda
Shintaro Kasahara
Koichi Sato
Sadamitsu Ichijo
Hiroaki Shimokawa
- 出版者
- 日本循環器学会
- 雑誌
- Circulation Journal (ISSN:13469843)
- 巻号頁・発行日
- pp.CJ-17-1103, (Released:2017-11-02)
- 参考文献数
- 17
- 被引用文献数
-
3
From August 26th to 30th, the 2017 Annual Congress of the European Society of Cardiology (ESC 2017) was held in Barcelona, Spain. Despite the terrorism tradegy just before the ESC congress, the congress attracted many medical professionals from all over the world to discuss the recent topics in cardiovascular medicine in more than 500 sessions, including COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS Trial), CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study), and ORION (which assessed the effect of a novel siRNA inhibitor to PCSK9 on reductions in low-density lipoprotein cholesterol). Japanese cardiologists and the Japanese Circulation Society greatly contributed to the congress. This report briefly introduces some late-breaking registry results, late-breaking clinical trials, and ESC Guidelines from the ESC 2017 Congress.